Compare Cigna Corp (CI) vs Centene Corp (CNC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Centene Corp — how do they compare? Cigna Corp trades at $302.59 (market cap $80.55B), while Centene Corp trades at $68.55 (market cap $33.72B). The key difference: Cigna Corp is far larger — about 2.4× Centene Corp's market cap, and Cigna Corp pays a 2.05% dividend while Centene Corp pays none. Which is the better fit depends on your goals.
| CI | CNC | |
|---|---|---|
Market Cap | $80.55B | $33.72B |
Sector | Health | Health |
52-Week High | $311.00 | $68.72 |
52-Week Low | $244.41 | $25.21 |
Enterprise Value | $103.65B | $26.35B |
Dividend Yield | 2.05% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Centene Corp
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →
